Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in mice. Involvement of allopregnanolone biosynthesis

European Neuropsychopharmacology

Volumn 20, Issue 3, 2010, Pages 195-206

  Sasso, Oscar ^a   La Rana, Giovanna ^a   Vitiello, Sergio ^b,c   Russo, Roberto ^a   D'Agostino, Giuseppe ^a   Iacono, Anna ^a   Russo, Emilio ^f   Citraro, Rita ^f   Cuzzocrea, Salvatore ^d,e   Piazza, Pier Vincenzo ^b,c   De Sarro, Giovanbattista ^f   Meli, Rosaria ^a   Calignano, Antonio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b INSTITUT FRANÇOIS MAGENDIE   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d UNIVERSITY OF MESSINA   (Italy)

^e IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^f Faculty of Medicine and Surgery   (Italy)

Author keywords

Acylethanolamide; Allopregnanolone; Brainstem; Neurosteroids; Pentobarbital induced LORR; PPARs

Indexed keywords

2 [4 [2 [3 CYCLOHEXYL 1 (4 CYCLOHEXYLBUTYL)UREIDO]ETHYL]PHENYLTHIO] 2 METHYLPROPIONIC ACID; 3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; CALCIUM ACTIVATED POTASSIUM CHANNEL; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); FINASTERIDE; GLUTETHIMIDE; NEUROSTEROID; PALMIDROL; PENTOBARBITAL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; STEROIDOGENIC ACUTE REGULATORY PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; ELECTROENCEPHALOGRAM; FOURIER TRANSFORM MASS SPECTROMETRY; HYPNOSIS; KNOCKOUT MOUSE; MALE; MASS FRAGMENTOGRAPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RIGHTING REFLEX; ROTAROD TEST; SINGLE DRUG DOSE; STEROIDOGENESIS;

ANIMALS; BRAIN STEM; DRUG SYNERGISM; HYPNOTICS AND SEDATIVES; MALE; MICE; PALMITIC ACIDS; PENTOBARBITAL; PPAR ALPHA; PREGNANOLONE;

EID: 75449110544     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2009.09.003     Document Type: Article

References (54)

1. Benani A., Heurtaux T., Netter P., and Minn A. Activation of peroxisome proliferator-activated receptor alpha in rat spinal cord after peripheral noxious stimulation. Neurosci. Lett. 369 (2004) 59-63
2. Ben-Shabat S., Fride E., Sheskin T., Tamiri T., Rhee M.H., Vogel Z., Bisogno T., De Petrocellis L., Di Marzo V., and Mechoulam R. An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. Eur. J. Pharmacol. 353 (1998) 23-31
3. Bose H.S., Lingappa V.R., and Miller W.L. The steroidogenic acute regulatory protein, StAR, works only at the outer mitochondrial membrane. Endocr Res. 28 (2002) 295-308
4. Brown B.B., and Shryne J.E. EEG theta activity and fast activity sleep in cats as related behavioral traits. Neuropsychologia 2 (1964) 311-326
5. Burade V.S., Jain M.R., Khan F.A., Saha S.G., and Subhedar N. Involvement of corticosteroid-like neurosteroids in pentobarbital-induced sleep. NeuroReport 8 (1996) 139-141
6. Cadas H., di Tomaso E., and Piomelli D. Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain. J. Neurosci. 17 (1997) 1226-1242
7. Calignano A., La Rana G., Giuffrida A., and Piomelli D. Control of pain initiation by endogenous cannabinoids. Nature 394 (1998) 277-281
8. Calignano A., La Rana G., and Piomelli D. Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide. Eur. J. Pharmacol. 11 (2001) 191-198
9. Costa B., Conti S., Giagnoni G., and Colleoni M. Therapeutic effect of the endogenous fatty acid amide, palmitoylethanolamide, in rat acute inflammation: inhibition of nitric oxide and cyclo-oxygenase systems. Br. J. Pharmacol. 137 (2002) 413-420
10. Daan S., Beersma D.G., and Borbely A.A. Timing of human sleep: recovery process gated by a circadian pacemaker. Am. J. Physiol. 246 (1984) R161-R183
11. Damianisch K., Rupprecht R., and Lancel M. The influence of subchronic administration of the neurosteroid allopregnanolone on LORR in the rat. Neuropsychopharmacology 25 (2001) 576-584
12. D'Agostino G., La Rana G., Russo R., Sasso O., Iacono A., Esposito E., Mattace Raso G., Cuzzocrea S., Lo Verme J., Piomelli D., Meli R., and Calignano A. Acute intracerebroventricular administration of palmitoylethanolamide, an endogenous peroxisome proliferator-activated receptor-alpha agonist, modulates carrageenan-induced paw edema in mice. J. Pharmacol. Exp. Ther. 322 (2007) 1137-1143
13. D'Agostino G., La Rana G., Russo R., Sasso O., Iacono A., Esposito E., Mattace Raso G., Cuzzocrea S., Loverme J., Piomelli D., Meli R., and Calignano A. Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-kappaB nuclear signalling in dorsal root ganglia. Eur J Pharmacol. 24 (2009) 54-59
14. Deboer T., Ruijgrok G., and Meijer J.H. Short light-daek cycles affect LORR in mice. Eur. J. NeuroSci. 26 (2007) 3518-3523
15. De Sarro G.B., Masuda Y., Ascioti C., Audino M.G., and Nistico G. Behavioural and ECoG spectrum changes induced by intracerebral infusion of interferons and interleukin 2 in rats are antagonized by naloxone. Neuropharmacology 29 (1990) 167-179
16. De Sarro G., Ammendola D., Nava F., and De Sarro A. Effects of some excitatory amino acid antagonists on imipenem-induced seizures in DBA/2 mice. Brain Res. 671 (1995) 131-140
17. De Sarro G., Palma E., Costa N., Marra R., Gratteri S., De Sarro A., and Rotiroti D. Effects of compounds acting on GABA(B) receptors in the pentylenetetrazole kindling model of epilepsy in mice. Neuropharmacology 39 (2000) 2147-2161
18. Di Marzo V., Melck D., Orlando P., Bisogno T., Zagoory O., Bifulco M., Voge l., and De Petrocellis L. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells. Biochem J. 358 (2001) 249-255
19. Franken P., Malafosse A., and Tafti M. Biochemistry. Genetic variation in EEG activity during sleep in inbred mice. Am. J. Physiol. 275 (1998) R1127-R1137
20. Genovese T., Mazzon E., Di Paola R., Cannavò G., Muià C., Bramanti P., and Cuzzocrea S. Role of endogenous ligands for the peroxisome proliferators activated receptors alpha in the secondary damage in experimental spinal cord trauma. Exp. Neurol. 194 (2005) 267-278
21. Haley T.J., and Mc Cormick W.G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol. 12 (1957) 12-15
22. Jung-Testas I., and Baulieu E.E. Steroid hormone receptors and steroid action in rat glial cells of the central and peripheral nervous system. J. Steroid Biochem. Mol. Biol. 65 (1998) 243-251
23. Kainu T., Wikstrom A.C., Gustafsson J.A., and Pelto-Huikko M. Localization of the peroxisome proliferator-activated receptor in the brain. NeuroReport 5 (1994) 2481-2485
24. Keller A.F., Breton J.D., Schlicnter R., and Poisbeau P. Production of 5alpha-reduced neurosteroids is developmentally regulated and shapes GABA(A) miniature IPSCs in lamina II of the spinal cord. J. Neurosci. 24 (2004) 907-915
25. King S.R., Manna P.R., Ishii T., Syapin P.J., Ginsberg S.D., Wilson K., Walsh L.P., Parker K.L., Stocco D.M., Smith R.G., and Lamb D.J. An essential component in steroid synthesis, the steroidogenic acute regulatory protein, is expressed in discrete regions of the brain. J. Neurosci. 22 (2002) 10613-10620
26. Lambert D.M., Vandevoorde S., Diependaele G., Govaerts S.J., and Robert A.R. Anticonvulsant activity of N-Palmitoylethanolamide, a putative endocannabinoid, in mice. Epilepsia. 42 (2001) 321-327
27. Lambeth J.D., Xu X.X., and Glover M. Cholesterol sulfate inhibits adrenal mitochondrial cholesterol side chain cleavage at a site distinct from cytochrome P-450scc. Evidence for an intramitochondrial cholesterol translocator. J. Biol. Chem. 262 (1987) 9181-9188
28. Lancel M., Faulhaber J., Schiffelholz T., Romeo E., Di Michel F., Holsboer F., and Rupprecht R. Allopregnanolone affects LORR in a benzodiazepine-like fashion. J. Pharmacol. Exp. Ther. 282 (1997) 1213-1218
29. Lemberger T., Desvergne B., and Wahli W. Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. Annu. Rev. Cell Dev. Biol. 12 (1996) 335-363
30. Lo Verme J., Fu J., Astarita G., La Rana G., Russo R., Calignano A., and Piomelli D. The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol. Pharmacol. 67 (2005) 15-19
31. Lo Verme J., Russo R., La Rana G., Fu J., Farthing J., Mattace-Raso G., Meli R., Hohmann A., Calignano A., and Piomelli D. Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha. J. Pharmacol. Exp. Ther. 319 (2006) 1051-1061
32. Macdonald R.L., and Olsen R.W. GABAA receptor channels. Annu. Rev. Neurosci. 17 (1994) 569-602
33. Mathieu A.P., Fleury A., Ducharme L., Lavigne P., and LeHoux J.G. Insights into steroidogenic acute regulatory protein (StAR)-dependent cholesterol transfer in mitochondria: evidence from molecular modeling and structure-based thermodynamics supporting the existence of partially unfolded states of StAR. J. Mol. Endocrinol. 29 (2002) 327-345
34. Matsumoto K., Satoh T., Bing L.H., Ohta H., and Watanabe H. Effects of forced shaking stress at low temperature on pentobarbital-induced LORRing in mice. Gen. Pharmacol. 22 (1991) 729-733
35. Melis M., Pillola G., Luchicchi A., Muntoni A.L., Yasar S., Goldberg S.R., and Pistis M. Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors. J. Neurosci. 28 (2008) 13985-13994
36. Mendelson W.B., Martin J.V., Perlis M., Wagner R., Majewska M.D., and Paul S.M. Sleep induction by an adrenal steroid in the rat. Psychopharmacology 93 (1987) 226-229
37. Miller W.L. Steroidogenic enzymes. Endocr. Dev. 13 (2008) 1-18
38. Moreno S., Farioli-Vecchioli S., and Ceru M.P. Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS. Neurosci. 123 (2004) 131-145
39. Paul S.M., and Purdy RH. Neuroactive steroids. FASEB J. 6 (1992) 2311-2322
40. Paxinos G., and Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates. second ed (2001), Academic Press, San Diego
41. Petrosino S., Palazzo E., de Novellis V., Bisogno T., Rossi F., Maione S., and Di Marzo V. Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats. Neuropharmacology 52 (2007) 415-422
42. Privalle C.T., Mc Namara B.C., Dhariwal M.S., and Jefcoate C.R. ACTH control of cholesterol side-chain cleavage at adrenal mitochondrial cytochrome P-450scc. Regulation of intramitochondrial cholesterol transfer. Mol. Cell. Endocrinol. 53 (1987) 87-101
43. Puia G., Mienville J.M., Matsumoto K., Takahata H., Watanabe H., Costa E., and Guidotti A. On the putative physiological role of allopregnanolone on GABA(A) receptor function. Neuropharmacology 44 (2003) 49-55
44. Rodriguez E.M., Désarnaud F., and García O.P. Diurnal variation of arachidonoylethanolamine, palmitoylethanolamide and oleoylethanolamide in the brain of the rat. Life Sci. 76 (2006) 30-37
45. Rupprecht R., di Michele F., Hermann B., Ströhle A., Lancel M., Romeo E., and Holsboer F. Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology. Brain Res. Rev. 37 (2001) 59-67
46. Sierra A. Neurosteroids: the StAR protein in the brain. J Neuroendocrinol. 16 (2004) 787-793
47. Stocco D.M. StAR protein and the regulation of steroid hormone biosynthesis. Annu. Rev. Physiol. 63 (2001) 193-213
48. Stocco D.M. Tracking the role of a star in the sky of the new millennium. Mol. Endocrinol. 15 (2001) 1245-1254
49. Sulcova E., Mechoulam R., and Fride E. Biphasic effects of anandamide. Pharmacol. Biochem. Behav. 59 (1998) 347-352
50. Thomson M. Does cholesterol use the mitochondrial contact site as aconduit to the steroidogenic pathway?. Bioessays 25 (2003) 252-258
51. Tobler I., and Borbely A.A. Sleep EEG in the rat as a function of prior waking. Electroencephalogr. Clin. Neurophysiol. 64 (1986) 74-76
52. Twyman R.E., and Mcdonald R.L. Neurosteroid regulation of GABAA receptor single-channel kinetic properties of mouse spinal cord neurons in culture. J. Physiol. 456 (1992) 215-245
53. Vallée M., Rivera J.D., Koob G.F., Purdy R.H., and Fitzgerald R.L. Quantification of neurosteroids in rat plasma and brain following swim stress and allopregnanolone administration using negative chemical ionization gas chromatography/mass spectrometry. Anal. Biochem. 287 (2000) 153-166
54. Watanabe K., Matsunga T., Nakamura S., Kimura T., Ho I.K., Yoshimura H., and Yamamoto I. Pharmacological effects in mice of anandamide and its related fatty acid ethanolamides, and enhancement of cataleptogenic effect of anandamide by phenylmethylsulfonyl fluoride. Biol. Pharm. Bull. 22 (1999) 366-370